SDIX is a leading immuno-solutions company specializing in high-quality antibody-based solutions for the IVD, anatomic pathology, biotechnology, and pharmaceutical markets. With over 30 years of experience, SDIX develops innovative and results-oriented products, including IHC antibodies, IVD reagents, and custom formulation blending, to help customers achieve their diagnostic and commercialization objectives.
As a wholly owned subsidiary of OriGene Technologies, SDIX is known for its large-scale GMP antibody production facilities located in Delaware and Maine. With a focus on performance, specificity, and quality, SDIX is dedicated to innovating and partnering with customers to create a healthier tomorrow.
Generated from the website